• Basel Medical Group closed a registered direct offering of 6,000,000 units at US$ 1.33 per unit.
• Gross proceeds totaled US$ 7.98 million; estimated net proceeds were about US$ 7.28 million.
• Each unit included one ordinary share and one Common Warrant; no pre-funded warrants were issued.
• Common Warrants are exercisable immediately at 110% of the unit price; they expire five years from issuance.
• Shares outstanding rose to 7,582,111 from 1,582,111; 6,000,000 Common Warrants remain outstanding.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610091632PRIMZONEFULLFEED9843245) on October 09, 2026, and is solely responsible for the information contained therein.